Gregorio Perez-Cordon

Gregorio Perez-Cordon

Auto-generated profile, based on publicly available information

Gregorio Perez-Cordon

University of Granada

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2015 in Current Biology
Verified
Journal Article
Closed access
GTGuifré Torruella
Guifré Torruella
AMAlex de Mendoza
Alex de Mendoza
XGXavier Grau-Bové
Xavier Grau-Bové
MAMeritxell Antó
Meritxell Antó
MCMark A. Chaplin
Mark A. Chaplin
IRIñaki Ruiz-Trillo
Iñaki Ruiz-Trillo

30 December 2014 in Cell Research
Verified
Journal Article
Open access
PDF file
PYPengfei Yuan
Pengfei Yuan
HZHongmin Zhang
Hongmin Zhang
CCChangzu Cai
Changzu Cai
SZShiyou Zhu
Shiyou Zhu
YZYuexin Zhou
Yuexin Zhou
WWWensheng Wei
Wensheng Wei
As a gram-positive, spore-forming anaerobic bacillus, Clostridium difficile (C. difficile) is responsible for severe and fatal pseudomembranous colitis, and poses the most urgent antibiotic resistance threat worldwide. Epidemic C. difficile is the leading cause of antibiotic-associated diarrhoea globally, especially diarrhoea due to the emergence of hypervirulent strains associated with high mortality and morbidity. TcdB, one of the key virulence factors secreted by this bacterium, enters host cells through a poorly understood mechanism to elicit its pathogenic effect. Here we report the first identification of the TcdB cellular receptor, chondroitin sulfate proteoglycan 4 (CSPG4). CSPG4 was initially isolated from a whole-genome human shRNAmir library screening, and its role was confirmed by both TALEN- and CRISPR/Cas9-mediated gene knockout in human cells. CSPG4 is critical for TcdB binding to the cell surface, inducing cytoskeleton disruption and cell death. A direct interaction between the N-terminus of CSPG4 and the C-terminus of TcdB was confirmed, and the soluble peptide of the toxin-binding domain of CSPG4 could protect cells from the action of TcdB. Notably, the complete loss of CSPG4/NG2 decreased TcdB-triggered interleukin-8 induction in mice without significantly affecting animal mortality. Based on both the in vitro and in vivo studies, we propose a dual-receptor model for TcdB endocytosis. The discovery of the first TcdB receptor reveals a previously unsuspected role for CSPG4 and provides a new therapeutic target for the treatment of C. difficile infection.

1 April 2014 in Fish & Shellfish Immunology
Verified
Journal Article
Closed access
GPGregorio Pérez-Cordón
Gregorio Pérez-Cordón
Itziar EstensoroItziar Estensoro
Itziar Estensoro
LBLaura Benedito-Palos
Laura Benedito-Palos
JCJosep Calduch-Giner
Josep Calduch-Giner
ASAriadna Sitja-Bobadilla
Ariadna Sitja-Bobadilla
JPJaume Pérez-Sánchez
Jaume Pérez-Sánchez

1 October 2008 in Veterinary Parasitology
Verified
Journal Article
Closed access
GCG. Pérez Cordón
G. Pérez Cordón
APA. Hitos Prados
A. Hitos Prados
DRDesire Romero-Molina
Desire Romero-Molina
MMM. Sánchez Moreno
M. Sánchez Moreno
APA. Pontes
A. Pontes
MRM.J. Rosales
M.J. Rosales

2 June 2009 in Journal of Natural Products
Verified
Journal Article
Closed access
CMClotilde Marín
Clotilde Marín
SBSamira Boutaleb-Charki
Samira Boutaleb-Charki
JDJesús G. Díaz
Jesús G. Díaz
OHOscar Huertas
Oscar Huertas
MRMaría J. Rosales
María J. Rosales
MSManuel Sánchez-Moreno
Manuel Sánchez-Moreno

11 May 2008 in Parasitology Research
Verified
Journal Article
Closed access
PDF file
GCG. Peréz Cordón
G. Peréz Cordón
OSO. Cordova Paz Soldan
O. Cordova Paz Soldan
FVF. Vargas Vásquez
F. Vargas Vásquez
JSJ. R. Velasco Soto
J. R. Velasco Soto
LBLl. Sempere Bordes
Ll. Sempere Bordes
MRM. J. Rosales
M. J. Rosales